Mark Leschly's Net Worth
$365 Million
Who is Mark Leschly?
Mark Leschly has an estimated net worth of $365 Million. This is based on reported shares across multiple companies, which include Anacor Pharmaceuticals, Inc., NGM BIOPHARMACEUTICALS INC, TERCICA INC, Everyday Health, Inc., Cara Therapeutics, Inc., ON24 INC., Vanda Pharmaceuticals Inc., INOTEK PHARMACEUTICALS CORP, ChargePoint Holdings, Inc., IntraLinks Holdings, Inc., SENOMYX INC, ReachLocal Inc, NephroGenex, Inc., BLUEFLY INC, NITROMED INC, ADVANCIS PHARMACEUTICAL CORP, and VERENIUM CORP.
SEC CIK
Mark Leschly's CIK is 0001120545
Past Insider Trading and Trends
2004 was Mark Leschly's most active year for acquiring shares with 15 total transactions. Mark Leschly's most active month to acquire stocks was the month of April. 2004 was Mark Leschly's most active year for disposing of shares, totalling 33 transactions. Mark Leschly's most active month to dispose stocks was the month of March. 2010 saw Mark Leschly paying a total of $22,263,226.40 for 24,818,265 shares, this is the most they've acquired in one year. In 2017 Mark Leschly cashed out on 6,290,503 shares for a total of $81,776,539.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Everyday Health, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -4.57M |
$10.09 | -$46,175,132.67 |
0
|
Dec 3 - Dec 5
| |||
Form 4
| +290.11% | 4.46M |
$13.02 | -$1,199,402.40 | 6M |
Apr 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cara Therapeutics, Inc. (CARA) Snapshot price: $0.532
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +16.30% | 500K |
$18.19 | $9,095,700.00 | 3.57M |
Mar 31
| |||
Form 4
| +14.99% | 400K |
$4.87 | $1,949,202.91 | 3.07M |
Mar 16 - Mar 17
| |||
Form 4
|
∞
| 2.67M |
$11.00 | $2,483,998.00 | 2.67M |
Feb 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ON24 INC. (ONTF) Snapshot price: $7.76
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.64M |
$50.00 | -$14,748,250.00 | 3.64M |
Feb 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vanda Pharmaceuticals Inc. (VNDA) Snapshot price: $3.6255
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -22.47% | -540.00K |
$14.98 | -$8,090,236.00 | 1.86M |
Nov 15
| |||
Form 4
|
—
|
0
|
$11.79 | -$158,823.43 | 2.4M |
Nov 6
| |||
Form 4
|
∞
| 2.4M |
—
|
—
| 2.4M |
Apr 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INOTEK PHARMACEUTICALS CORP (RCKT) Snapshot price: $28.77
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1,131.82% | 2.64M |
$6.00 |
—
| 2.87M |
Feb 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||